Inhalation April 2022 35
Dual cavity multi-dose DPI
e MRX006 is a dual cavity, multi-dose dry powder
inhaler (DPI) device. It offers superior technology,
tailored to current regulations and high-performance
expectations. Based on the open-inhale-close prin-
ciple, it is designed to accommodate a combination
formulation of two or more active pharmaceutical
ingredients (APIs) to enable filling of the generic
DPI, for instance with fluticasone, umeclidinium
and vilanterol.
Merxin
UK: +44 1553 406070
info@merxin.com
www.merxin.com
Dry powder inhalation capsule portfolio
Lonza's Capsugel
®
Zephyr™ dry powder inhalation
capsule portfolio is a comprehensive capsule prod-
uct offering, featuring customized DPI capsules and
dedicated equipment in place for efficient, phase-
appropriate capsule filling. e Zephyr DPI portfolio
addresses the need for highly customized solutions for
pulmonary route delivery methods and is supported
by Lonza's inhalation and drug development and par-
ticle engineering capabilities. is integrated product
and service offering enables consistent and optimal
release performance for inhalation drugs.
Lonza Capsules & Health Ingredients
US: +1 888 783-6361
www.capsugel.com
Capsules for pulmonary drug
delivery technologies
Dry powder inhalers (DPIs) come in many forms:
single-dose devices with the drug either pre-dispensed
into capsules and blisters or multi-dose devices with
a bulk drug reservoir and a measuring instrument.
With extensive expertise in this field, Qualicaps
®
offers a broad portfolio of capsules in gelatin and
HPMC especially designed for inhaled drug delivery,
with superior aerosolization and puncturing proper-
ties, even for very hygroscopic and very moisture-sen-
sitive inhalation formulations.
Qualicaps
®
Europe, S.A.U.
Spain: +34 91 6 63 0 800
www.qualicaps.com
